Skip to main content
RLAY logo

RLAY · Relay Therapeutics, Inc. · Executive Compensation

Track RLAY — free
$16.12 +0.21 (+1.32%) At close · Nov 20
Market Cap
$3.56B
Shares
220.96M
Volume · Nov 20 3.98M Avg daily vol (3M) 2.93M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Sanjiv K. Patel $4,646,454
Thomas Catinazzo $1,568,613
Brian R. Adams $1,177,329
Fiscal 2024
Executive Total
Sanjiv K. Patel $13,079,301
Donald Bergstrom $6,613,397
Peter Rahmer $4,963,636
Thomas Catinazzo $4,400,994
Brian R. Adams $4,365,263
Fiscal 2023
Executive Total
Sanjiv K. Patel $19,770,838
Donald Bergstrom $8,573,063
Peter Rahmer $6,782,446
Thomas Catinazzo $5,219,149
Brian R. Adams $4,510,775
Fiscal 2022
Executive Total
Sanjiv K. Patel $8,121,840
Donald Bergstrom $3,783,338
Thomas Catinazzo $2,457,265
Brian R. Adams $2,455,974
Peter Rahmer $2,427,957
Fiscal 2021
Executive Total
Sanjiv K. Patel $8,532,948
Donald Bergstrom $3,539,792
Brian R. Adams $1,889,635
Thomas Catinazzo $1,836,279
Andy Porter $1,754,609
Fiscal 2020
Executive Total
Sanjiv K. Patel $3,576,319
Donald Bergstrom $1,105,092
Brian R. Adams $800,201
Fiscal 2019
Executive Total
Sanjiv K. Patel $3,529,596
Donald Bergstrom $916,516
Brian R. Adams $619,497

Executive changes

Person Change Filed
Habib Dable Appointed 2025-11-06
Lonnel Coats Appointed 2025-11-06
Jami Ruben
“Ms. Rubin’s resignation is not the result of any dispute or disagreement with the Company.”
Resigned 2025-06-11
Sekar Kathiresan, M.D. Appointed 2022-07-27
Dipchand (Deep) Nishar
“Mr. Nishar’s resignation was not the result of any dispute or disagreement with the Company, the Company’s management or the Board on any matter relating to the Company’s operations, policies or practices.”
Resigned 2021-12-09

Leadership

Key facts CIK 1812364 CUSIP 75943R102 13F (30d) 276 filings 247 filers Visit website Investor relations